In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or evenmonths after the infection has gone. The aim of this study was to describe the effect ofadjunctive individualized homeopathic treatment delivered to Long-COVID-19 patients withpreviously confirmed symptomatic SARS-CoV-2 infection.
All patients had been tested positive for SARS-CoV-2 before having developed
Long-COVID-19 symptoms. Several testing methods were carried out in each patient to
analyze a SARS-CoV-2 infection. For a confirmed infection, at least 3 out of these 5
tests had to be positive. Tests for the orthomyxoviruses influenza A and B, human
metapneumovirus (hMPV) and paramyxoviruses were negative unless stated otherwise.
The homeopathic physician treated all Long-COVID-19 patients by individualized
homeopathy. Repertorization of the symptoms of the current pandemic and a search in the
current homeopathic literature on COVID-19 was performed using computer program. All
available homeopathic medicinal products (HMPs) could be chosen by the treating
physician.
Modified MONARCH criteria were assessed post hoc by all authors. Deviations were solved
by discussion in person. Clinical outcome of case reports was evaluated using the
"Modified Naranjo Criteria for Homeopathy-Causal Attribution Inventory". Eight points is
assumed as the limit for potential correlation between homeopathic therapy and
amelioration of the symptoms or healing in chronic cases.
Drug: Homeopathic medicines
Globules were administered orally..
Other Name: Homeopathic medicinal products
Inclusion Criteria:
Long COVID-19 symptoms following recovery from SARS-CoV-2 infection
Exclusion Criteria:
Patients not signing informed consent
Sigmund Freud Private University
Vienna 2761369, Austria
Michael Frass, MD, Study Director
Institute for Homeopathic Research